Vertebral compression fractures in pediatric patients with intestinal failure: A prospective observational case

Asia Smith1, Shweta S Namjoshi2, Laura K Bachrach3

  • 1Howard University School of Medicine, USA.

PubMed

Insights

Intestinal failure associated bone disease is a risk for children on parenteral nutrition. A study found 21% of pediatric patients with intestinal failure had vertebral fractures, with two-thirds being asymptomatic, highlighting the need for screening.

Area of Science:

  • Pediatric Gastroenterology
  • Bone Metabolism
  • Parenteral Nutrition

Background:

  • Intestinal failure associated bone disease (IFABD) significantly impacts bone health in children dependent on parenteral nutrition (PN).
  • Early detection and management of IFABD are crucial for long-term patient outcomes.

Purpose of the Study:

  • To determine the prevalence of vertebral fractures (VF) in pediatric patients with intestinal failure (IF).
  • To assess the utility of lateral thoracolumbar x-rays using Genant criteria for detecting VF in this population.

Main Methods:

  • Observational study of pediatric patients with IF at a single center.
  • Lateral thoracolumbar x-rays were used to detect vertebral fractures based on Genant criteria.
  • Data collected as part of a larger observational database study on IF long-term outcomes.

Main Results:

  • 14 pediatric patients with IF were included; 3 (21%) had confirmed vertebral fractures.
  • Short bowel syndrome was the most common cause of IF (64%).
  • Two of the three patients with VF were asymptomatic, underscoring the potential for silent bone disease.

Conclusions:

  • Vertebral fractures are prevalent in pediatric patients with IF, even in asymptomatic individuals.
  • Further investigation and multicenter studies are warranted to establish risk factors and screening guidelines.
  • Early detection of VF can inform treatment decisions, such as initiating bisphosphonate therapy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.5K
Muscles of the Vertebral Column01:27

Muscles of the Vertebral Column

The back muscles that lie deep into the thoracolumbar fascia are called intrinsic or true back muscles. These muscles are divided into four layers: superficial, intermediate, deep, and deepest layers.
Superficial Layer:
The superficial layer consists primarily of the splenius muscles, which include the splenius capitis and splenius cervicis. These muscles are mainly responsible for the head and cervical spine movements, including extension, rotation, and lateral bending. The splenius capitis...
3.3K